Innovative Medicines Initiative

Scope: Considering that this is a newly-identified virus, the scope of this topic remains broad and must address at least one of the following objectives: 1. development of antivirals as well as other types of therapeutics to address a rapid response to the current COVID-19 outbreak; 2. development of therapeutics to address the current and/or future coronavirus outbreaks; 3. development of diagnostics, ensuring rapid evaluation of candidates based on existing technologies; 4. development of fast and reliable tools that go beyond the state of the art for detection of COVID-19 carriers and symptomatic individuals suspected of COVID-19 infection